EPA:ERF • FR0014000MR3
The current stock price of ERF.PA is 67.54 EUR. In the past month the price decreased by -4.5%. In the past year, price increased by 38.4%.
ChartMill assigns a technical rating of 8 / 10 to ERF.PA. When comparing the yearly performance of all stocks, ERF.PA is one of the better performing stocks in the market, outperforming 86.44% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to ERF.PA. Both the profitability and the financial health of ERF.PA get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months ERF.PA reported a non-GAAP Earnings per Share(EPS) of 3.72. The EPS increased by 12.73% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.48% | ||
| ROA | 6.29% | ||
| ROE | 15.21% | ||
| Debt/Equity | 0.82 |
20 analysts have analysed ERF.PA and the average price target is 70.01 EUR. This implies a price increase of 3.65% is expected in the next year compared to the current price of 67.54.
For the next year, analysts expect an EPS growth of 10.84% and a revenue growth 4.81% for ERF.PA
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SRT3 | SARTORIUS AG-VORZUG | 39.5 | 17.896B | ||
| DIM | SARTORIUS STEDIM BIOTECH | 34.25 | 17.787B | ||
| 56S1 | SARTORIUS STEDIM BIOTECH | 33.94 | 17.626B | ||
| SRT | SARTORIUS AG | 32.59 | 14.766B | ||
| QIA | QIAGEN N.V. | 17.9 | 8.443B | ||
| 1SXP | SCHOTT PHARMA AG& CO KGAA | 13.46 | 2.298B | ||
| EVT | EVOTEC SE | N/A | 2.168B | ||
| GXI | GERRESHEIMER AG | 6.81 | 705.998M | ||
| FF | FINE FOODS & PHARMACEUTICALS | 16.41 | 254.242M | ||
| ALECR | EUROFINS CEREP-REGR | N/A | 174M |
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and, consumer products industries and to governments. The company operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain.
EUROFINS SCIENTIFIC
23 Val Fleuri
Luxembourg LU
Employees: 62696
Phone: 35226185320
Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and, consumer products industries and to governments. The company operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain.
The current stock price of ERF.PA is 67.54 EUR. The price increased by 0.18% in the last trading session.
EUROFINS SCIENTIFIC (ERF.PA) has a dividend yield of 1.07%. The yearly dividend amount is currently 0.52.
ERF.PA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
ERF.PA stock is listed on the Euronext Paris exchange.
EUROFINS SCIENTIFIC (ERF.PA) will report earnings on 2026-04-22.